Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis

Sands, Bruce E ; Peyrin-Biroulet, Laurent ; Loftus, Edward V ; Danese, Silvio ; Colombel, Jean-Frédéric ; Törüner, Murat ; Jonaitis, Laimas ; Abhyankar, Brihad ; Chen, Jingjing ; Rogers, Raquel ; Lirio, Richard A ; Bornstein, Jeffrey D ; Schreiber, Stefan

The New England journal of medicine, 2019-09, Vol.381 (13), p.1215-1226 [Periódico revisado por pares]

United States: Massachusetts Medical Society

Texto completo disponível